Silence Therapeutics (LON:SLN) Earns Buy Rating from Peel Hunt
Peel Hunt reaffirmed their buy rating on shares of Silence Therapeutics (LON:SLN) in a research note issued to investors on Friday, ThisIsMoney.Co.Uk reports.
Shares of LON:SLN opened at GBX 143 ($1.87) on Friday. Silence Therapeutics has a twelve month low of GBX 40 ($0.52) and a twelve month high of GBX 175 ($2.29). The stock’s 50 day moving average price is GBX 68.14. The firm has a market capitalization of $103.28 million and a price-to-earnings ratio of -5.46.
About Silence Therapeutics
Featured Story: Futures Contract
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.